Home > List All Publishers > Cutting Edge Information

Cutting Edge Information

Pharmaceutical research intelligence firm Cutting Edge Information, was founded in 2002 by Jason Richardson (Chief Executive Officer) and Adam Bianchi (Chief Operating Officer). The company is located in Durham, North Carolina, and offers customized consulting and a growing library of targeted and insightful pharmaceutical research reports. Cutting Edge Information delivers an innovative new approach to distributing comprehensive pharmaceutical and biotechnology benchmarking data. CEI offers objective, comprehensive primary and secondary research on critical industry issues as well as customized consulting services.

List of reports from Cutting Edge Information

Autoimmune Market Forecast to 2014 6/1/2009 \| published by: Cutting Edge Information ... $3 billion annually. Nine mid-level products will generate $400 million, at minimum, by 2014. For autoimmune drugs, reaching blockbuster-level success is an expectation as much as a goal. Whether you're exploring your options or need ... \| more...	$7,695.00
Benchmarking Drug Safety and Pharmacovigilance 3/1/2010 \| published by: Cutting Edge Information ... and even some more recently in 2010 — have prompted the pharma industry to invest more in drug safety. Beyond changes to investments and added resources, companies are beginning to regard drug safety in more ... \| more...	$7,695.00
Best Practices in MSL Team Management 7/1/2010 \| published by: Cutting Edge Information ... to shape clinical and commercial strategy. These responsibilities have amplified the professional and educational experience required of MSLs, and superlative MSL management now requires a deft balancing act that includes resource planning, HR concerns and ... \| more...	$7,695.00
Business Development: Accelerating the Deal 5/1/2008 \| published by: Cutting Edge Information ... alliances, organizations across the industry depend on other firms’ discovery, development and marketing capabilities to reach a range of different objectives. Use this report to perfect your team's approach to different elements of the deal-making ... \| more...	$7,695.00
Canadian Pharmaceutical Sales Management 11/1/2007 \| published by: Cutting Edge Information ... as many as 4 to 6 different reps from some larger companies during a given month. Combining access issues with stringent self-imposed and government regulations on how reps can sell their products and companies are ... \| more...	$7,695.00
The Changing MSL Role: Proving Value Through Performance Measurement 6/15/2008 \| published by: Cutting Edge Information ... demands, have led companies to put a premium on building productive relationships with key opinion leaders and supporting company objectives through medical education. Today, MSLs are evolving into a more independent, highly strategic function. Innovative ... \| more...	$7,695.00
Clinical Operations: Benchmarking Per-Patient Trial Costs, Staffing and Adaptive Design 1/1/2011 \| published by: Cutting Edge Information ... causing drugmakers to adopt a bottom-line perspective and demand greater R&D efficiency. Greater efficiency leads to cost- and time-savings that could mean the difference in beating the competition to market and adding time to a ... \| more...	$7,695.00
Clinical Outsourcing Strategy: Selecting Partners and Managing Relationships 4/1/2009 \| published by: Cutting Edge Information ... expertise to trial sponsors, complementing companies' core competencies. But poor CRO management will drive up trial costs, delay a drug's time to market, or at worst, lead to trial cancellation and threaten a drug's future. \| more...	$7,695.00
Companion Diagnostics and Biomarker Development 2/1/2012 \| published by: Cutting Edge Information ... companion diagnostics (CDx) offer companies the ability to target a subset of patients for testing — unleashing the potential for greater efficacy, accelerated regulatory approval and better reimbursement. Companion diagnostics are not suitable for every ... \| more...	$7,695.00
Countering Generic and Biosimilar Threats 6/1/2010 \| published by: Cutting Edge Information ... billion. To retain market share in the battle against generics, brands must devise a well-rounded strategy. But knowing which moves to make - and when - is no easy task, and decisions on how much ... \| more...	$7,695.00
Designing Patient Communications Programs 8/1/2009 \| published by: Cutting Edge Information ... communications — and ultimately, increase prescription volume and improve patient adherence. A successful campaign depends heavily on appropriate resource support and allocation. Our patient education program budgets and staffing benchmarks are the most current available ... \| more...	$7,695.00
Determining European KOL Compensation Fair-Market Value Benchmarks 1/1/2011 \| published by: Cutting Edge Information ... are now applying similar approaches to Europe and other parts of the world. To remain compliant with government regulations, industry codes and various agencies’ guidelines, drug and device companies must understand the fair-market value (FMV) ... \| more...	$7,695.00
Diabetes Market Forecast to 2015 1/1/2010 \| published by: Cutting Edge Information ... top 10 drug manufacturers. This market forecast includes CEI analysts’ original research — generated from surveys and interviews with physicians and diabetes marketing and development executives. Use their input to uncover the latest trends in ... \| more...	$9,995.00
Driving Successful Pharma Brands: Case Studies of Real Product Launches 1/1/2009 \| published by: Cutting Edge Information ... 13 US brands of all sizes, representing various therapeutic areas, drug classes and sales potentials. Each easy-to-access brand profile details critical components of a brand’s commercialization efforts, including sampling, journal ads, DTC advertising, thought leader ... \| more...	$7,695.00
Emerging Markets Clinical Development Series Africa 11/1/2010 \| published by: Cutting Edge Information ... But Africa offers tremendous expertise and opportunity for drug and device companies looking for cost-effective study sites and appropriate patient populations. As challenging as Africa may seem, drug companies have made commitments to improve healthcare ... \| more...	$7,695.00
Emerging Markets Clinical Development Series Asia (China, India, Other Emerging Asian Countries) 11/1/2010 \| published by: Cutting Edge Information ... among investigators has come in-line with Western expectations for Good Clinical Practice. Asia presents an interesting mix of Western knowledge and Eastern practice that has resulted in significant scientific and medical advances. As more companies ... \| more...	$7,695.00
Emerging Markets Clinical Development Series Brazil, Russia, India and China (BRIC) 11/1/2010 \| published by: Cutting Edge Information ... (or recruitment challenges) that plague studies in North America and Western Europe, unparalleled access to untapped patient populations, and new opportunities to meet the growing medical needs of these countries. Despite vast promise as the ... \| more...	$7,695.00
Emerging Markets Clinical Development Series Central and Eastern Europe 11/1/2010 \| published by: Cutting Edge Information ... clinical studies. In fact, the population of Central and Eastern European countries exceeds that of either the United States or the five largest Western European markets combined. Furthermore, there is a lower saturation of competing ... \| more...	$7,695.00
The Evolving Global Meeting Management Strategy 6/1/2008 \| published by: Cutting Edge Information ... planners now play a strategic role. To bolster this transition, most companies employ centralized structures for their meeting planning departments. More than ever before, meeting planners interact with and serve an entire organization. Becoming a ... \| more...	$7,695.00
Evolving Medical Information Call Centers through Performance Measurement and Process Improvement 1/1/2009 \| published by: Cutting Edge Information ... Use Evolving Medical Information Call Centers through Performance Measurement and Process Improvement to understand how medical information leaders are tightening their ships through increased performance measurement and more streamlined processes. The most innovative teams are ... \| more...	$7,695.00
Health Outcomes Liaisons: Managing a Field-Based Team that Speaks the Payer’s Language 10/1/2011 \| published by: Cutting Edge Information ... with payers and secure the best reimbursement, companies increasingly deploy health outcomes liaisons (HOLs). HOLs forge connections with key target audiences by communicating critical health economics and outcomes research (HEOR) data. Trailblazing companies have assembled ... \| more...	$7,695.00
Improve Market Research Impact 1/1/2009 \| published by: Cutting Edge Information ... to determine the correct markets to enter at the earliest positive clinical signs. This great emphasis on early informed decisions has caused the role of market research — and related areas, such as competitive intelligence, ... \| more...	$7,695.00
In Vitro Diagnostics: Development Through Postmarket 4/1/2008 \| published by: Cutting Edge Information ... groups. Regulators, payer organizations, healthcare providers and laboratory technicians ultimately determine the value of a product -- and how well it will do in the market. For that reason, strategic market-focused product development and effective ... \| more...	$7,695.00
Investigator Initiated Trial Management 9/1/2011 \| published by: Cutting Edge Information ... publication in a medical journal to advance a drug’s — and the company’s — profile and credibility. Supported by dedicated resources, effective IIT teams reach that point by navigating process delays while maintaining regulatory compliance ... \| more...	$7,695.00
Investigator-Initiated Trials: Building Superior IIT Capabilities 4/1/2008 \| published by: Cutting Edge Information ... usage, reach new patient populations, generate data for publication and solidify relationships with key opinion leaders. Once considered an afterthought, IITs are now often regarded as critical pieces of product development strategy. Reflecting this different ... \| more...	$7,695.00

< prev 1 2 3 next >